Denis Chem Lab
73.00
-0.45(-0.61%)
Market Cap₹101.28 Cr
PE Ratio11.70
IndustryHealthcare
Company Performance:
1D-0.61%
1M-5.11%
6M-13.68%
1Y-33.00%
5Y+26.96%
View Company Insightsright
More news about Denis Chem Lab
31Mar 26
Denis Chem Lab: Varun Daga Family Trust Files Substantial Acquisition Disclosure
Varun Daga Family Trust has filed a substantial acquisition disclosure under SEBI Regulation 29(1) for Denis Chem Lab Limited, acquiring 2,67,499 equity shares representing 1.93% stake through off-market transaction. The coordinated acquisition with persons acting in concert resulted in aggregate holdings of 13,37,498 shares (9.64%) of the company's paid-up equity share capital.
 no imag found
14Feb 26
Denis Chem Lab Limited Reports Strong Q3FY26 Results with 88.6% Profit Growth
Denis Chem Lab Limited announced strong Q3FY26 financial results with net profit rising 88.6% to ₹332.16 lakh and revenue increasing 6.2% to ₹4,551.83 lakh. The Board approved results on February 14, 2026, under SEBI regulations, with the company maintaining focus on transfusion solutions manufacturing.
 no imag found
13Aug 25
Denis Chem Lab Reports 19% Surge in Q1 Profit, Revenue Grows 4.9%
Denis Chem Lab Limited, a pharmaceutical company, announced strong Q1 FY2026 results. Net profit increased by 19% to Rs 247.50 crore, while revenue from operations grew 4.9% to Rs 4,327.59 crore. Earnings per share rose to Rs 1.78 from Rs 1.50 in the previous year. The company demonstrated effective cost management despite increased material costs. Managing Director Himanshu C. Patel highlighted the company's resilience and operational strength. Auditors Shah & Shah Associates issued an unmodified opinion on the financial results.
 no imag found
Denis Chem Lab
73.00
-0.45
(-0.61%)
1 Year Returns:-33.00%
Industry Peers
Sun Pharmaceutical
1,799.20
(-2.45%)
Divis Laboratories
6,667.00
(-1.92%)
Torrent Pharmaceuticals
4,410.80
(-2.80%)
Cipla
1,401.00
(-1.21%)
Dr Reddys Laboratories
1,303.50
(-1.18%)
Zydus Life Science
1,077.70
(-0.75%)
Lupin
2,267.70
(-0.38%)
Mankind Pharma
2,375.60
(-1.85%)
Aurobindo Pharma
1,426.40
(-0.66%)
Laurus Labs
1,362.00
(-1.43%)